Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Anika Therapeutics, Inc.

Anika Therapeutics, Inc. (ANIK) Stock Overview

Explore Anika Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

ANIK●NASDAQ
HealthcareMedical - Specialties
$19.66
$0.29(1.43%)
U.S. Market opens in 14h 18m

Anika Therapeutics, Inc. (ANIK)

Meyka AI Score

Z

Key Financials

Market Cap263.1M
P/E Ratio-73.35
EPS (TTM)$0.49
ROE-0.03%
Fundamental Analysis

AI Price Forecasts

1 Month$21.69
3 Months$20.95
1 Year Target$10.48

ANIK Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Anika Therapeutics, Inc. (NASDAQ: ANIK) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Anika Therapeutics, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of ANIK on the NASDAQ shows an RSI of 39.82, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $10.48 for the NASDAQ listing.

Key metrics behind Anika Therapeutics, Inc.'s NASDAQ-traded stock include a P/E ratio of -73.35 and a market capitalization of 263.1M. Combined with our AI analysis, these give both institutional and retail investors a clear view of ANIK on the NASDAQ.

Price Performance (NASDAQ: ANIK)

1-Day Change
-1.43%
5-Day Change
-2.82%
1-Month Change
-6.82%
3-Month Change
34.38%
6-Month Change
39.14%
Year-to-Date (YTD) Change
104.58%
1-Year Change
109.15%
3-Year Change
5.19%
5-Year Change
-53.81%
All-Time (Max) Change
461.71%

Contact Information

https://www.anika.com
781 457 9000
32 Wiggins Avenue, Bedford, MA, 01730

Company Facts

2,350 Employees
IPO DateMay 3, 1993
CountryUS
Actively Trading

Frequently Asked Questions